Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (104,624)	$ (89,532)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,868	8,360
Amortization and impairment of internal-use software	1,248	1,052
Stock-based compensation expense	51,100	30,462
Loss (gain) on disposal of property and equipment	(5)	(9)
Changes in operating assets and liabilities:
Accounts receivable, net	(2,227)	460
Inventories	(1,568)	(673)
Deferred cost of revenue	(1,925)	1,154
Prepaid expenses and other current assets	(1,928)	7,259
Operating lease right-of-use assets	1,749	1,833
Other assets	408	(765)
Accounts payable (included related party amounts of $325 and $12,567, respectively)	(2)	(19,154)
Accrued expenses and other current liabilities (included related party amounts of $-3215 and $3,310, respectively)	(1,889)	2,454
Deferred revenue (included related party amounts of $-10,670 and $(8,246), respectively)	(14,398)	(13,116)
Operating lease liabilities	(2,070)	(2,179)
Other liabilities	(92)	(664)
Net cash used in operating activities	(69,355)	(73,040)
Cash flows from investing activities:
Purchases of property and equipment	(419)	(1,614)
Proceeds from sale of property and equipment	5	0
Capitalized internal-use software costs	(2,281)	(1,286)
Net cash used in investing activities	(2,695)	(2,900)
Cash flows from financing activities:
Proceeds from exercise of stock options	69	1,533
Payments of deferred offering costs	(62)	0
Payments for taxes related to net share settlement of equity awards	(121)	0
Net cash (used in) provided by financing activities	(114)	1,533
Effect of exchange rates on cash and cash equivalents	(334)	623
Net decrease in cash, cash equivalents and restricted cash	(72,498)	(73,784)
Cash, cash equivalents and restricted cash-beginning of period	395,222	561,755
Cash, cash equivalents and restricted cash-end of period	322,724	487,971
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses	176	28
Stock-based compensation capitalized for internal-use software costs	1,188	573
Issuance of common stock upon release of restricted stock units under the 2022 Annual Incentive Plan	18,630
Deferred offering costs during the period included in accounts payable and accrued expenses	100	0
Cash and cash equivalents	314,351	479,398
Restricted cash, current	1,399	1,599
Restricted cash, noncurrent	6,974	6,974
Total cash, cash equivalents and restricted cash	$ 322,724	$ 487,971